Cannabinoids and reproduction: A lasting and intriguing history

Pharmaceuticals

Volumn 3, Issue 10, 2010, Pages 3275-3323

  Cacciola, Giovanna ^a   Chianese, Rosanna ^a   Chioccarelli, Teresa ^a   Ciaramella, Vincenza ^a   Fasano, Silvia ^a   Pierantoni, Riccardo ^a   Meccariello, Rosaria ^b   Cobellis, Gilda ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF NAPLES PARTHENOPE   (Italy)

Author keywords

Cannabinergic system; Female reproduction; Hypothalamuspituitary gonads axis; Male reproduction

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N MORPHOLINO 1H PYRAZOLE 3 CARBOXAMIDE; 2 ARACHIDONOYLGLYCEROL; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; ANANDAMIDE; BENZYLSULFONYL FLUORIDE; BUSERELIN; CANNABINOID DERIVATIVE; CANNABINOID RECEPTOR; CAPSAZEPINE; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; DEACETYLLEVONANTRADOL; DELTA8 TETRAHYDROCANNABINOL; DEXANABINOL; DRONABINOL; ENDOCANNABINOID; FATTY ACID AMIDASE; METHANANDAMIDE; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; N ARACHIDONOYLDOPAMINE; N OLEOYLETHANOLAMINE; NOLADIN ETHER; PALMIDROL; PROLACTIN; RIMONABANT; UNCLASSIFIED DRUG; VIRODHAMINE;

BIRTH CONTROL; DRUG MECHANISM; FEMALE GENITAL SYSTEM; FERTILITY; HUMAN; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; LOW DRUG DOSE; MALE GENITAL SYSTEM; METABOLISM; NERVE CELL NETWORK; NONHUMAN; OBESITY; OVARY; PLACENTA; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; REPRODUCTION; REVIEW; SIGNAL TRANSDUCTION; SPERMATOGENESIS; SPERMATOZOON; TESTIS; UTERUS;

EID: 78650157389     PISSN: None     EISSN: 14248247     Source Type: Journal    
DOI: 10.3390/ph3103275     Document Type: Review

References (331)

1. Read, B.E. Chinese medicinal plants. Peking Natural History Bulletin; Mit Press: Beijing, China, 193; Columns IV and V, p. 152.
2. Johnson, M. R.; Melvin, L. S. Cannabinoids as Therapeutic Agents; Mechoulam, R., Ed., CRC Press: New York, NY, USA, 1986; pp. 121-145.
3. Bowker, J. The Oxford Dictionary of World Religions; Oxford University Press: Oxford, UK, 1997; p. 142
4. Booth, M. Cannabis: A History. Doubleday 2003, 339.
5. Baker, D.; Pryce, G.; Giovannoni, G.; Thompson, A.J. The therapeutic potential of cannabis. Lancet Neurol. 2003, 2, 291-298.
6. Robson, P. Therapeutic aspects of cannabis and cannabinoids. Br. J. Psychiatry. 2001, 178, 107-115.
7. Solomon, P. Medical management of drug dependence. J. Amer. Medic. Assoc. 1968, 206, 1521-1526.
8. Carter, G.T.; Weydt, P.; Kyashna-Tocha, M.; Abrams, D.I. Medicinal cannabis: rational guidelines for dosing. IDrugs 2004, 7, 464-470.
9. Wilkinson, D.J. Myths and mandrakes. J. R. Soc. Med. 2003, 96, 255-256.
10. Mechoulam, R.; Gaoni, Y.J. A total synthesis of delta 1 tetrahycrocannabinol, the active constituents of hashish. Am. Chem. Soc. 1965, 87, 3273-3275.
11. Elsohly, M.A.; Slade, D. Chemical constituents of marijuana: the complex mixture of natural cannabinoids. Life Sci. 2005, 78, 539-548.
12. Smith, F.L.; Fujimori, K.; Lowe, J.; Welch, S.P. Characterization of delta9-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats. Pharmacol. Biochem. Behav. 1998, 60, 183-191.
13. Melvin, L.S.; Johnson, M.R. Structure-activity relationships of tricyclic and nonclassical bicyclic cannabinoids. NIDA Res. Monogr. 1987, 79, 31-47.
14. Devane, W.A.; Dysarz, F.A. 3rd; Johnson, M.R.; Melvin, L.S.; Howlett, A.C. Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. 1988, 34, 605-613.
15. Matsuda, L.A.; Lolait, S.J.; Brownstein, M.J.; Young, A.C.; Bonner, T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990, 346, 561-564.
16. Munro, S.; Thomas, K.L.; Abu-Shaar, M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993, 365, 61-65.
17. Howlett, A.C. The cannabinoid receptors. Prost. Other Lipid Mediat. 2002, 68, 619-631.
18. Childers, S.R. Activation of G-proteins in brain by endogenous and exogenous cannabinoids. AAPS J. 2006, 8, E112-E117.
19. Howlett, A.C.; Blume, L.C.; Dalton, G.D. CB(1) cannabinoid receptors and their associated proteins. Curr. Med. Chem. 2010, 17, 1382-1393.
20. Howlett, A.C. The CB1 cannabinoid receptor in the brain. Neurobiol Dis 1998, 5, 405-416.
21. Glass, M.; Felder, C.C. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. J. Neurosci. 1997, 17, 5327-5333.
22. Twitchell, W.; Brown, S.; Mackie, K. Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons. J. Neuriphysiol. 1997, 78, 43-50.
23. Caulfield, M.P.; Brown, D.A. Cannabinoid receptor agonists inhibit Ca current in NG108-15 neuroblastoma cells via a pertussis toxin-sensitive mechanism. Br. J. Pharmacol. 1992, 106, 231-232.
24. Mackie, K.; Hille, B. Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc. Natl. Acad. Sci. USA 1992, 89, 3825-3829.
25. Oz, M. Receptor-independent effects of endocannabinoids on ion channels. Curr. Pharm. Des. 2006, 12, 227-239.
26. Lauckner, J.E.; Hille, B.; Mackie, K. The cannabinoid agonist WIN55, 212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins. Proc. Natl. Acad. Sci. USA 2005, 102, 19144-19149.
27. Netzeband, J.G.; Conroy, S.M.; Parson, K.L.; Groul, D.L. Cannabinoids enhance NMDA-elicited calcium signals in cerebellar granule neurons in culture. J. Neurosci. 1999, 19, 8765-8777.
28. Fimiani, C.; Mattocks, D.; Cavani, F.; Salzet, M.; Deutsch, D.G.; Pryor, S.; Bilfinger, T.V.; Stefano, G.B. Morphine and anandamide stimulate intracellular calcium transients in human arterial endothelial cells: coupling to nitric oxide release. Cell Signal 1999, 3, 189-193.
29. Bouaboula, M.; Poinot-Chazel, C.; Bourrie, B.; Canat, X.; Calandra, B.; Rinaldi-Carmona, M.; Le Fur, G.; Casellas, P. Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1. Biochem. J. 1995, 312, 637-641.
30. Derkinderen, P.; Valjent, E.; Toutant, M.; Corvol, J.C.; Enslen, H.; Ledent, C.; Trzaskos, J.; Caboche, J.; Girault, J.A. Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus. J. Neurosci. 2003, 23, 2371-2382.
31. Felder, C.C.; Joyce, K.E.; Briley, E.M.; Mansouri, J.; Mackie, K.; Blond, O.; Lay, Y.; Ma, A.L.; Mitchell, R.L. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Mol. Pharmacol. 1995, 48, 443-450.
32. Diaz-Laviada, I.; Ruiz-Llorente, L. Signal transduction activated by cannabinoid receptors. Mini Rev. Med. Chem. 2005, 5, 619-630.
33. Wenger, T.; Fernández-Ruiz, J.J.; Ramos, J.A. Immunocytochemical demonstration of CB1 cannabinoid receptors in the anterior lobe of the pituitary gland. J. Neuroendocrinol. 1999, 11, 873-878.
34. Kaminski, N.E.; Abood, M.E.; Kessler, F.K.; Martin, B.R.; Schatz, A.R. Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoidmediated immune modulation. Mol. Pharmacol. 1992, 42, 736-742.
35. Bouaboula, M.; Rinaldi, M.; Carayon, P.; Carillon, C.; Delpech, B.; Shire, D.; Le Fur, G.; Casellas, P. Cannabinoid-receptor expression in human leukocytes. Eur. J. Biochem. 1993, 214, 173-180.
36. Taylor, A.H.; Ang, C.; Bell, S.C.; Konje, J.C. The role of the endocannabinoid system in gametogenesis, implantation and early pregnancy. Hum. Reprod. Update 2007, 13, 501-513.
37. Kulkarni-Narla, A.; Brown, D.R. Localization of CB1-cannabinoid receptor immunoreactivity in the porcine enteric nervous system. Cell Tissue Res. 2000, 302, 73-80.
38. Ishac, E.J.; Jiang, L.; Lake, K.D.; Varga, K.; Abood, M.E.; Kunos, G. Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves. Br. J. Pharmacol. 1996, 118, 2023-2028.
39. Wenger, T.; Ledent, C.; Csernus, V.; Gerendai, I. The central cannabinoid receptor inactivation suppresses endocrine reproductive functions. Biochem. Biophys. Res. Commun. 2001, 284, 363-368.
40. Rice, W.; Shannon, J.M.; Burton, F.; Fiedeldey, D. Expression of a brain-type cannabinoid receptor (CB1) in alveolar Type II cells in the lung: regulation by hydrocortisone. Eur. J. Pharmacol. 1997, 327, 227-232.
41. Farquhar-Smith, W.P.; Jaggar, S.I.; Rice, A.S. Attenuation of nerve growth factor-induced visceral hyperalgesia via cannabinoid CB(1) and CB(2)-like receptors. Pain 2002, 97, 11-21.
42. Niederhoffer, N.; Hansen, H.H.; Fernandez-Ruiz, J.J.; Szabo. B. Effects of cannabinoids on adrenaline release from adrenal medullary cells. Br. J. Pharmacol. 2001, 134, 1319-1327.
43. Cota, D.; Marsicano, G.; Tschöp, M., Grübler, Y.; Flachskamm, C.; Schubert, M.; Auer, D.; Yassouridis, A.; Thöne-Reineke, C.; Ortmann, S.; Tomassoni, F.; Cervino, C.; Nisoli, E.; Linthorst, A.C.; Pasquali, R.; Lutz, B.; Stalla, G.K.; Pagotto, U. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J. Clin. Invest. 2003, 112, 423-431.
44. Osei-Hyiaman, D.; De Petrillo, M.; Pacher. P.; Liu, J.; Radaeva, S.; Bátkai, S.; Harvey-White, J.; Mackie, K.; Offertáler, L.; Wang, L.; Kunos, G. Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J. Clin. Invest. 2005, 115, 1298-1305.
45. Galiegue, S.; Mary, S.; Marchand, J; Dussossoy, D.; Carriere, D.; Carayon, P.; Bouaboula, M.; Shire, D.; Le Fur, G.; Casellas, P. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur. J. Biochem. 1995, 232, 54-61.
46. Pettit, D.A.; Anders, D.L.; Harrison, M.P.; Cabral, G.A. Cannabinoid receptor expression in immune cells. Adv. Exp. Med. Biol. 1996, 402, 119-129.
47. Facci, L.; Dal Toso, R.; Romanello, S.; Buriani, A.; Skaper, S.D.; Leon, A. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc. Natl. Acad. Sci. USA 1995, 92, 3376-3380.
48. Walter, L.; Franklin, A.; Witting, A.; Wade, C.; Xie, Y.; Kunos, G.; Mackie, K.; Stella, N. Nonpsychotropic cannabinoid receptors regulate microglial cell migration. J. Neurosci. 2003, 23, 1398-1405.
49. Van Sickle, M.D.; Duncan, M.; Kingsley, P.J.; Mouihate, A.; Urbani, P.; Mackie, K.; Stella, N.; Makriyannis, A.; Piomelli, D.; Davison, J.S.; Marnett, L.J.; Di Marzo, V; Pittman, Q.J.; Patel, K.D.; Sharkey, K.A. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 2005, 310, 329-332.
50. Onaivi, E.S. Neuropsychobiological evidence for the functional presence and expression of cannabinoid CB2 receptors in the brain. Neuropsychobiology 2006, 54, 231-246.
51. Begg, M.; Pacher, P.; Batkai, S.; Osei-Hyiaman, D.; Offertaler, L.; Mo, F.M.; Liu, J.; Kunos, G. Evidence for novel cannabinoid receptors. Pharmacol. Ther. 2005, 106, 133-145.
52. Fredriksson, R.; Hoglund, P.J.; Gloriam, D.E.; Lagerstrom, M.C.; Schioth, H.B. Seven evolutionarily conserved human rhodopsin G protein-coupled receptors lacking close relatives. FEBS Lett. 2003, 554, 381-388.
53. Lauckner, J.E.; Bensen, J.B.; Chen, H.Y.; Lu, H.C.; Hille, B., Mackie, K. GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current. Proc. Natl. Acad. Sci. USA 2008, 105, 2699-2704.
54. Henstridge, C.M.; Balenga, N.A.B.; Ford, L.A.; Ross, R.A.; Waldhoer, M.; Irving, A.J. The GPR55 ligand L-α-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation. FASEB J. 2009, 23, 183-193.
55. Mackie, K.; Stella, N. Cannabinoid receptors and endocannabinoids: evidence for new players. Am. Assoc. Pharm. Sci. J. 2006, 8, E298-E306.
56. Kapur, A.; Zhao, P.; Sharir, H.; Bai, Y.; Caron, M.G.; Barak, L.S.; Abood, M.E. Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands. J. Biol. Chem. 2009, 284, 29817-29827.
57. Ryberg, E.; Larsson, N.; Sjögren, S.; Hjorth, S.; Hermansson, N.O.; Leonova, J.; Elebring, T.; Nilsson, K.; Drmota, T.; Greasley, PJ. The orphan receptor GPR55 is a novel cannabinoid receptor. Br. J. Pharmacol. 2007, 152, 1092-1101.
58. Daly, C.J.; Ross, R.A.; Whyte, J.; Henstridge, C.M.; Irving, A.J.; McGrath, J.C. Fluorescent ligand binding reveals heterogeneous distribution of adrenoceptors and 'cannabinoid-like' receptors in small arteries. Br. J. Pharmacol. 2010, 159, 787-796.
59. Sakamoto, Y.; Inoue, H.; Kawakami, S.; Miyawaki, K.; Miyamoto, T.; Mizuta, K. Itakura, M. Expression and distribution of Gpr119 in the pancreatic islets of mice and rats: predominant localization in pancreatic polypeptide-secreting PP-cells. Biochem. Biophys. Res. Commun. 2006, 351, 474-480.
60. Overton, H.A.; Babbs, A.J.; Doel, S.M.; Fyfe, M.C.; Gardner, L.S.; Griffin, G.; Jackson, H.C.; Procter, M.J.; Rasamison, C.M.; Tang-Christensen, M.; Widdowson, P.S.; Williams, G.M.; Reynet, C. Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents. Cell Metab. 2006, 3, 167-175.
61. Kedei, N.; Szabo, T.; Lile, J.D.; Treanor, J.J.; Olah, Z.; Iadarola, M.J.; Blumberg, P.M. Analysis of the native quaternary structure of vanilloid receptor 1. J. Biol. Chem. 2001, 276, 28613-28619.
62. Caterina, M.J.; Schumacher, M.A.; Tominaga, M.; Rosen, T.A.; Levine, J.D.; Julius, D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997, 389, 816-824.
63. Gunthorpe, M.J; Harries, M.H.; Prinjha, R.K.; Davis, J.B.; Randall, A. Voltage- and timedependent properties of the recombinant rat vanilloid receptor (rVR1). J. Physiol. 2000, 525, 747-759.
64. Bhave, G.; Hu, H.J.; Glauner, K.S.; Zhu, W.; Wang, H.; Brasier, D.J.; Oxford, G.S.; Gereau, R.W. Protein kinase C phosphorylation sensitizes but does not activate the capsaicin receptor transient receptor potential vanilloid 1 (TRPV1). Proc. Natl. Acad. Sci. USA 2003, 100, 12480-12485.
65. De Petrocellis, L.; Bisogno, T.; Maccarrone, M.; Davis, J.B.; Finazzi-Agrò, A.; Di Marzo, V. The activity of anandamide at vanilloid VR1 receptors requie facilitated tran sport across the cell membrane and is limited by intracellular metabolism. J. Biol. Chem. 2001, 276, 12856-12863.
66. Yamamoto, Y.; Taniguchi, K. Immunolocalization of VR1 and VRL1 in rat larynx. Auton. Neurosci. 2005, 117, 62-65.
67. Liu, L.; Chen, L.; Liedtke, W.; Simon, S.A.Changes in osmolality sensitize the response to capsaicin in trigeminal sensory neurons. J. Neurophysiol. 2007, 97, 2001-2015.
68. Maccarrone, M.; Barboni, B.; Paradisi, A.; Bernabo, N.; Gasperi, V.; Pistilli, M.G.; Fezza, F.; Lucidi, P.; Mattioli, M. Characterization of the endocannabinoid system in boar spermatozoa and implications for sperm capacitation and acrosome reaction. J. Cell Sci. 2005, 118, 4393-4404.
69. Grimaldi, P.; Orlando, P.; Di Siena S.; Lolicato, F.; Petrosino, S.; Bisogno, T.; Geremia, R.; De, Petrocellis, L.; Di Marzo, V. The endocannabinoid system and pivotal role of the CB2 receptor in mouse spermatogenesis. Proc. Natl. Acad. Sci. USA 2009, 106, 11131-11136.
70. Pertwee, R.G. Pharmacology of cannabinoid receptor ligands. Curr. Med. Chem. 1999, 6, 635-664.
71. Devane, W.A.; Hanus, L.; Breuer, A.; Pertwee,R.G.; Stevenson,L.A.; Griffin,G.; Gibson,D.; Mandelbaum,A.; Etinger,A.; Mechoulam,R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992, 258, 1946-1949.
72. Mechoulam, R.; Ben-Shabat, S.; Hanus, L.; Ligumsky, M.; Kaminski, N.E.; Schatz, A.R.; Gopher, A.; Almog, S.; Martin, B.R.; Compton, D.R.; Identification of an endogenous 2- monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 1995, 50, 83-90.
73. Sugiura, T.; Kodaka, T.; Nakane, S.; Miyashita, T.; Kondo, S.; Suhara, Y.; Takayama, H.; Waku, K.; Seki, C.; Baba, N.; Ishima,Y. Evidence that the cannabinoid CB1 receptor is a 2- arachidonoylglycerol receptor. Structure-activity relationship of 2-arachidonoylglycerol, etherlinked analogues, and related compounds. J. Biol. Chem. 1999, 274, 2794-2801.
74. Porter, A.C.; Sauer, J.M.; Knierman,M.D.; Becker,G.W.; Berna,M.J.; Bao,J.; Nomikos,G.G.; Carter,P.; Bymaster,F.P.; Leese,A.B.; Felder,C.C. Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. J. Pharmacol. Exp. Ther. 2002, 301, 1020-1024.
75. Ralevic, V. Cannabinoid modulation of peripheral autonomic and sensory neurotransmission. Eur. J. Pharmacol. 2003, 472, 1-21.
76. Di Marzo, V.; De Petrocellis, L.; Bisogno, T.; Melck, D. Metabolism of anandamide and 2- arachidonoylglycerol: an historical overview and some recent developments. Lipids 1999, 34 Suppl, S319-S325.
77. Ross, R.A.; Gibson, T.M.; Brockie, H.C.; Leslie, M.; Pashmi, G.; Craib, S.J.; Di Marzo, V.; Pertwee, R.G. Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens. Br. J. Pharmacol. 2001, 132, 631-640.
78. Lo Verme J.; Fu, J.; Astarita, G.; La Rana, G.; Russo, R.; Calignano, A.; Piomelli, D. The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide. Mol. Pharmacol. 2005, 67, 15-19.
79. Rinaldi-Carmona, M.; Barth,F.; Heaulme,M.; Shire,D.; Calandra,B.; Congy,C.; Martinez,S.; Maruani,J.; Neliat,G.; Caput,D.; SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 1994, 350, 240-244.
80. Rinaldi-Carmona, M.; Barth, F.; Millan, J.; Derocq, J.M.; Casellas, P.; Congy, C.; Oustric, D.; Sarran, M.; Bouaboula, M.; Calandra, B.; Portier, M.; Shire, D.; Breliere, J.C.; Le Fur, G.L. SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. J. Pharmacol. Exp. Ther. 1998, 284, 644-650.
81. MacLennan, S.J.; Reynen, P.H.; Kwan, J.; Bonhaus, D.W. Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1 and CB2 receptors. Br. J. Pharmacol. 1998, 124, 619-622.
82. Al-Hayani, A.; Davies, S.N. Cannabinoid receptor mediated inhibition of excitatory synaptic transmission in the rat hippocampal slice is developmentally regulated. Br. J. Pharmacol. 2000, 131, 663-665.
83. White, R.; Ho, W.S.; Bottrill, F.E.; Ford, W.R.; Hiley, C.R. Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries. Br. J. Pharmacol. 2001, 134, 921-929.
84. Di Marzo, V.; Fontana, A.; Cadas, H.; Schinelli, S.; Cimino, G.; Schwartz, JC.; Piomelli, D. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 1994, 372, 686-691.
85. Cadas, H.; di Tomaso, E.; Piomelli, D. Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain. J. Neurosci. 1997, 17, 1226-1242.
86. Sugiura, T.; Kondo, S.; Sukagawa, A.; Tonegawa, T.; Nakane, S.; Yamashita, A.; Waku, K. Enzymatic synthesis of anandamide, an endogenous cannabinoid receptor ligand, through Nacylphosphatidylethanolamine pathway in testis: involvement of Ca(2+)-dependent transacylase and phosphodiesterase activities. Biochem. Biophys. Res. Commun. 1996, 218, 113-117.
87. Schmid, P.C.; Reddy, PV.; Natarajan, V.; Schmid, H.H. Metabolism of N-acylethanolamine phospholipids by a mammalian phosphodiesterase of the phospholipase D type. J. Bio.l Chem. 1983, 258, 9302-9306.
88. Okamoto, Y.; Morishita, J.; Tsuboi, K.; Tonai, T.; Ueda, N. Molecular characterization of a phospholipase D generating anandamide and its congeners. J. Biol. Chem. 2004, 279, 5298-5305.
89. Leung, D.; Saghatelian, A.; Simon, G.M.; Cravatt, B.F. Inactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of - endocannabinoids. Biochemisty 2006, 45, 4720-4726.
90. Sun, Y.X.; Tsuboi, K.; Okamoto, Y.; Tonai, T.; Murakami, M.; Kudo, I.; Ueda, N. Biosynthesis of anandamide and N-palmitoylethanolamine by sequential actions of phospholipase A2 and lysophospholipase D. Biochem. J. 2004, 380, 749-756.
91. Liu, J.; Wang, L.; Harvey-White, J.; Osei-Hyiaman, D.; Razdan, R.; Gong, Q.; Chan, A.C.; Zhou, Z.; Huang, B.X.; Kim, H.Y.; Kunos, G. A biosynthetic pathway for anandamide. Proc. Natl. Acad. Sci. USA 2006, 103, 13345-13350.
92. Simon, G.M.; Cravatt, B.F. Endocannabinoid biosynthesis proceeding through glycerophospho- N-acyl ethanolamine and a role for alpha/beta-hydrolase 4 in this pathway. J. Biol. Chem. 2006, 281, 26465-26472.
93. Bisogno, T.; Melck, D.; De Petrocellis, L.; Di Marzo, V. Phosphatidic acid as the biosynthetic precursor of the endocannabinoid 2-arachidonoylglycerol in intact mouse neuroblastoma cells stimulated with ionomycin. J. Neurochem. 1999, 72, 2113-2119.
94. Stella, N.; Schweitzer, P.; Piomelli, D. A second endogenous cannabinoid that modulates longterm potentiation. Nature 1997, 388, 773-778.
95. Sugiura, T.; Kondo, S.; Sukagawa, A.; Nakane, S.; Shinoda, A.; Itoh, K.; Yamashita, A.; Waku, K. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys. Res. Commun. 1995, 215, 89-97.
96. Bisogno, T.; Howell, F.; Williams, G.; Minassi, A.; Cascio, M.G.; Ligresti, A.; Matias, I.; Schiano-Moriello, A.; Paul, P.; Williams, E.J.; et al. Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J. Cell. Biol. 2003, 163, 463-468.
97. Beltramo, M.; Stella, N.; Calignano, A.; Lin, S.Y.; Makriyannis, A.; Piomelli, D. Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science 1997, 277, 1094-1097.
98. Bojesen, I.N.; Hansen, H.S. Membrane transport of anandamide through resealed human red blood cell membranes. Lipid. Res. 2005, 46, 1652-1659.
99. Glaser, S.T.; Abumrad, N.A.; Fatade, F.; Kaczocha, M.; Studholme, K.M.; Deutsch, D.G. Evidence against the presence of an anandamide transporter. Proc. Natl. Acad. Sci. U S A. 2003, 100, 4269-4274.
100. Beltramo, M.; Piomelli, D. Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol. Neuroreport 2000, 27, 1231-1235.
101. Ligresti, A.; Morera, E.; Van Der Stelt, M.; Monory, K.; Lutz, B.; Ortar, G.; Di Marzo, V. Further evidence for the existence of a specific process for the membrane transport of anandamide. Biochem. J. 2004, 380, 265-272.
102. Ligresti, A.; De Petrocellis, L.; Hernán Pérez de la Ossa, D.; Aberturas, R.; Cristino, L.; Moriello, A.S.; Finizio, A.; Gil, M.E.; Torres, A.I.; Molpeceres, J.; Di Marzo, V. Exploiting nanotechnologies and TRPV1 channels to investigate the putative anandamide membrane transporter. PLoS One 2010, 5, e10239.
103. Rodgers, W.; Smith, K. Properties of glycolipid-enriched membrane rafts in antigen presentation. Crit. Rev. Immunol. 2005, 25, 19-30.
104. Bari, M.; Oddi, S.; De Simone, C.; Spagnolo, P.; Gasperi, V.; Battista, N.; Centonze, D.; Maccarrone, M. Type-1 cannabinoid receptors colocalize with caveolin-1 in neuronal cells. Neuropharmacology 2008, 54, 45-50.
105. Pike, L.J. Growth factor receptors, lipid rafts and caveolae: an evolving story. Biochem. Biophys. Acta 2005, 1746, 260-273.
106. Kaczocha, M.; Glaser, S.T.; Deutsch, D.G. Identification of intracellular carriers for the ndocannabinoid anandamide. Proc. Natl. Acad. Sci. USA 2009, 106, 6375-6380.
107. Schug, T.T.; Berry, D.C.; Shaw, N.S.; Travis, S.N.; Noy, N. Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors. Cell 2007, 129, 723-733.
108. Cravatt, B.F.; Giang, D.K.; Mayfield, S.P.; Boger, D.L.; Lerner, R.A.; Gilula, N.B. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 1996, 384, 83-87.
109. Dinh, T.P.; Freund, T.F.; Piomelli, D. A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation. Chem. Phys. Lipids. 2002, 121, 149-158.
110. Kozak, K.R; Marnett, L.J. Oxidative metabolism of endocannabinoids. Prost. Leukot. Essent. Fatty Acids 2002, 66, 211-220.
111. van der Stelt, M.; van Kuik, J.A.; Bari, M.; van Zadelhoff, G.; Leeflang, B.R.; Veldink, G.A.; Finazzi-Agrò, A.; Vliegenthart, J.F.; Maccarrone, M. Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase. J. Med. Chem. 2002, 45, 3709-3720.
112. Craib, S.J.; Ellington, H.C.; Pertwee, R.G.; Ross, R.A. A possible role of lipoxygenase in the activation of vanilloid receptors by anandamide in the guinea-pig bronchus. Br. J. Pharmacol. 2001, 134, 30-37.
113. Kozak, K.R.; Gupta, R.A.; Moody, J.S.; Ji, C.; Boeglin, W.E.; DuBois, R.N.; Brash, A.R.; Marnett, L.J. 15-Lipoxygenase metabolism of 2-arachidonylglycerol. Generation of a peroxisome proliferator-activated receptor alpha agonist. J. Biol. Chem. 2002, 277, 23278-23286.
114. Weber, A.; Ni, J.; Ling, K.H.; Acheampong, A.; Tang-Liu, D.D.; Burk, R.; Cravatt, B.F.; Woodward, D. Formation of prostamides from anandamide in FAAH knockout mice analyzed by HPLC with tandem mass spectrometry. J. Lipid. Res. 2004, 45, 757-763.
115. Ross, R.A.; Craib, S.J.; Stevenson, L.A.; Pertwee, R.G.; Henderson, A.; Toole, J.; Ellington, H.C. Pharmacological characterization of the anandamide cyclooxygenase metabolite: prostaglandin E2 ethanolamide. J. Pharmacol. Exp. Ther. 2002, 301, 900-907.
116. Cravatt, B.F., Lichtman, A.H. The enzymatic inactivation of the fatty acid amide class of signaling lipids. Chem. Phys. Lipids. 2002, 121, 135-148.
117. McKinney, M.K.; Cravatt, B.F. Structure and function of fatty acid amide hydrolase. Annu. Rev. Biochem. 2005, 74, 411-432.
118. Wei, B.Q.; Mikkelsen, T.S.; McKinney, M.K.; Lander, E.S.; Cravatt, B.F. A second fatty acid amide hydrolase with variable distribution among placental mammals. J. Biol. Chem. 2006, 281, 36569-36578.
119. Deutsch, D.G.; Chin, S.A. Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. Biochem. Pharmacol. 1993, 46, 791-796.
120. Mor, M.; Rivara, S.; Lodola, A.; Plazzi, P.V.; Tarzia, G.; Duranti, A.; Tontini, A.; Piersanti, G.; Kathuria, S.; Piomelli, D. Cyclohexylcarbamic acid 3'- or 4'-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies. J. Med. Chem. 2004, 47, 4998-5008.
121. Maccarrone, M.; Salvati, S.; Bari, M.; Finazzi-Agró. Anandamide and 2-arachidonoylglycerol inhibit fatty acid amide hydrolase by activating the lipoxygenase pathway of the arachidonate cascade. Biochem. Biophys. Res. Commun. 2000, 278, 576-583.
122. Kathuria, S.; Gaetani, S.; Fegley, D.; Valiño, F.; Duranti, A.; Tontini, A.; Mor, M.; Tarzia, G.; La Rana, G.; Calignano, A.; Giustino, A.; Tattoli, M.; Palmery, M.; Cuomo, V.; Piomelli, D. Modulation of anxiety through blockade of anandamide hydrolysis. Nat. Med. 2003, 9, 76-81.
123. Karlsson, M.; Reue, K.; Xia, Y.R.; Lusis, A.J.; Langin, D.; Tornqvist, H.; Holm, C. Exon-intron organization and chromosomal localization of the mouse monoglyceride lipase gene. Gene 2001, 272, 11-18.
124. Gulyas, A.I.; Cravatt, B.F.; Bracey, M.H.; Dinh, T.P.; Piomelli, D.; Boscia, F.; Freund, T.F. Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala. Eur. J. Neurosci. 2004, 20, 441-458.
125. Lu, D.; Vemuri, V.K.; Duclos, R.I., Makriyannis, A. The cannabinergic system as a target for anti-inflammatory therapies. Curr. Top. Med. Chem. 2006, 6, 1401-1426.
126. Walter, L.; Stella, N. Cannabinoids and neuroinflammation. Br. J. Pharmacol. 2004, 141, 775-785.
127. Guzman, M.; Sanchez, C.; Galve-Roperh, I. Cannabinoids and cell fate. Pharmacol. Ther. 2002, 95, 175-184.
128. Berdyshev, E.V. Cannabinoid receptors and the regulation of immune response. Chem. Phys. Lipids 2000, 108, 169-190.
129. Cota, D.; Marsicano, G.; Lutz, B.; Vicennati, V.; Stalla, G.K.; Pasquali, R.; Pagotto, U. Endogenous cannabinoid system as a modulator of food intake. Int. J. Obes. Relat Metab Disord. 2003, 27, 289-301.
130. Shepherd Gordon, M. The Synaptic Organization of the Brain (Fifth ed.). Oxford University Press: Oxford, UK/ New York, NY, USA, 2004.
131. Finlay, B.L.; Darlington, R.B.; Nicastro, N. Developmental structure in brain evolution. Behav. Brain Sci. 2001, 20, 263-308.
132. Wilson, R.I.; Nicoll, R.A. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 2001, 410, 588-592.
133. Adermark, L.; Lovinger, D.M. Retrograde endocannabinoid signalling at striatal synapses requires a regulated postsynaptic release step. Proc. Natl. Acad. Sci. USA 2007, 104, 20564-20569.
134. Gong, J.P.; Onaivi, E.S.; Ishiguro, H.; Liu, Q.R.; Tagliaferro, P.A.; Brusco, A.; Uhl, G.R. Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res. 2006, 1071, 10-23.
135. Terasawa, E. Gonadotropin-releasing hormone II: is this neuropeptide important for mammalian reproduction? Endocrinology 2003, 144, 3-4.
136. Pierantoni, R.; Cobellis, G.; Meccariello, R.; Fasano, S. Evolutionary aspects of cellular comunication in the vertebrate hypothalamo-hypophysio-gonadal axis. Int. Rev. Cytol. 2002, 218, 69-141.
137. Tsou, K.; Brown, S.; Sanudo-pena, M.C.; Mackie, K.; Walker, J.M. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 1998, 83, 393-411.
138. Cristino, L.; De Petrocellis, L.; Pryce, G.; Baker, D.; Guglielmotti, V.; Di Marzo, V. Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain. Neuroscience 2006, 139, 1405-1415.
139. Yang, H.T.; Karoum, F.; Felder, C.; Badger, H.; Wang, T.L.; Markey, S.P. GC/MS analysis of anandamide and quantification of N-arachidonoylphosphatidylethanolamides in various brain regions, spinal cord, testis, and spleen of the rat. J. Neurochem. 1999, 72, 1959-68.
140. Blankman, J.; Simon, G.M.; Cravatt, B. A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem. Biol. 2007, 14, 1347-1356.
141. Salio, C.; Doly, S.; Fischer, J.; Franzoni, M.F.; Conrath, M. Neuronal and astrocytic localization of the cannabinoid receptor-1 in the dorsal horn of the rat spinal cord. Neurosci. Lett. 2002, 329, 13-16.
142. Salio, C.; Fischer, J.; Franzoni, M.F.; Conrath, M. Pre- and postsynaptic localizations of the CB1 cannabinoid receptor in the dorsal horn of the rat spinal cord. Neuroscience 2002, 110, 755-764.
143. Soderstrom, K.; Leid, M.; Moore, F.L.; Murray, T.F. Behavioral, pharmacological and molecular characterization of an amphibian cannabinoid receptor. J. Neurochem. 2000, 75, 413-423.
144. Meccariello, R.; Chianese, R.; Cacciola, G.; Cobellis, G.; Pierantoni, R.; Fasano, S. Type-1 cannabinoid receptor expression in the frog, Rana esculenta, tissues: a possible involvement in the regulation of testicular activity. Mol. Reprod. Develop. 2006, 73, 551-558.
145. Cottone, E.; Forno, S.; Campantico, E.; Guastalla, A.; Voltrono, L.; Mackie, K.; Franzoni, M.F. Expression and distribution of CB1 cannabinoid receptors in the central nervous system of the African cichlid fish Pelvicachromis pulcher. J. Comp. Neurol. 2005, 485, 293-303.
146. Valenti, M.; Cottone, E.; Martinez, R.; De Pedro, N.; Rubio, M.; Viveros, M.P.; Franzoni, M.F.; Delgado, M.J.; Di Marzo, V. The endocannabinoid system in the brain of Carassius auratus and its possible role in the control of food intake. J. Neurochem. 2005, 95, 662-672.
147. Meccariello, R.; Franzoni, M.F.; Chianese, R.; Cottone, E.; Scarpa, D.; Donna, D.; Cobellis, G.; Guastalla, A.; Pierantoni, R.; Fasano, S. Interplay between the endocannabinoid system and GnRH1 in the forebrain of the anuran amphibian Rana esculenta. Endocrinol. 2008, 149, 2149-2158.
148. Schuel, H.; Burkman, L.J. A tale of two cells: endocannabinoid-signaling regulates functions of neurons and sperm. Biol. Reprod. 2005, 73, 1078-1086.
149. Stella, N. How might cannabinoids influence sexual behaviour? Proc. Natl. Acad. Sci. USA 2001, 98, 793-795.
150. Murphy, L.L.; Adrian, B.A.; Kohli, M. Inhibition of luteinizing hormone secretion by delta9- tetrahydrocannabinol in the ovariectomized rat: effect of pretreatment with neurotransmitter or neuropeptide receptor antagonists. Steroids 1999, 64, 664-671.
151. Pagotto, U.; Marsicano, G.; Cota, D.; Lutz, B.; Pasquali, R. The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endoc. Rev. 2006, 27, 73-100.
152. Gonzalez, S.; Manzanares, J.; Berrendero, F.; Wenger, T.; Corchero, J.; Bisogno, T.; Romero, J.; Fuentes, J.A.; Di Marzo, V.; Ramos, J.A.; Fernández-Ruiz, J. Identification of endocannabinoids and cannabinoid CB1 receptor mRNA in the pituitary gland. Neuroendocrinology 1999, 70, 137-145.
153. Gonzalez, S.; Bisogno, T.; Wenger, T.; Manzanares, J.; Milone, A.; Berrendero, F.; Di Marzo, V.; Ramos, J.A.; Fernandez-Ruiz, J.J. Sex steroid influence on cannabinoids CB1 receptor mRNA and endocannabinoid levels in the anterior pituitary gland. Biochem. Biophys. Res. Commun. 2000, 270, 260-266.
154. Wenger, T.; Toth, B.E.; Juaneda, C.; Leonardelli, J.; Tramu, G. The effects of cannabinoids on the regulation of reproduction. Life Sci. 1999, 65, 695-702.
155. Pagotto, U.; Marsicano, G.; Fezza, F.; Theodoropoulou, M.; Gruebler, Y.; Stalla, J.; Arzberger, T.; Milone, A.; Losa, M.; Di Marzo, V.; Lutz, B.; Stalla, G.K. Normal human pituitary gland and pituitary adenomas express cannabinoid receptor type 1 and synthesize endogenous cannabinoids: first evidence for a direct role of cannabinoids on hormone modulation at the human pituitary level. J. Clin. Endocrinol. Metab. 2001, 86, 2687-2696.
156. Cesa, R.; Guastalla, A.; Cottone, E.; Mackie, K.; Beltramo, M.; Franzoni, M.F. Relationships between CB1 cannabinoid receptors and pituitary endocrine cells in Xenopus laevis: an immunohistochemical study. Gen. Comp. Endocrinol. 2002, 125, 17-24.
157. Fernandez-Ruiz, J.J.; Munoz, R.M.; Romer, J.; Villanua, M.A.; Makryannis, A.; Ramos, J.A. Time course of the effects of differents cannabimimetics on prolactin and gonadotropin secretion: evidence for the presence of CB1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics. Biochem. Pharmacol. 1997, 53, 1919-1927.
158. Bonnin, A.; Ramos, J.A., Rodriguez de Fonseca, F.; Cebeira, M.; Fernandez-Ruiz, J.J. Acute effects of Δ9-tetrahydrocannbinol on tuberoinfundibular dopaminergic activity, anterior pituitary sensitivity to dopamine and prolactin release vary as a function of estrous cycle. Neuroendocrinology 1993, 58, 280-286.
159. Rodriguez de Fonseca, F.; Cebeira, M.; Ramos, J.A.; Martin, M.; Fernandez-Ruiz, J.J. Cannabinoid receptors in rat brain areas: sexual differences, fluctuations during estrous cycle and changes after gonadectomy and sex steroid replacement. Life Sci. 1994, 54, 159-170.
160. Hughes, C.L.; Everett, J.W.; Tyrey, L. Δ9-Tetrahydrocannabinol suppression of prolactin secretion is modulated by estrogens. Proc. Natl. Acad. Sci. USA 2003, 100, 2134-2139.
161. Scorticati, C.; Mohn, C.; De Laurentis, A.; Vissio, P.; Fernandez-Solari, J.; Seilicovich, A.; McCann, S.M.; Rettori, V. The effect of anandamide on prolactin secretion is modulated by estrogen. Proc. Natl. Acad. Sci. USA 2003, 100, 2134-2139.
162. Ho, B.Y.; Stadnicka, A.; Prather, P.L.; Buckley, A.R.; Current, L.L.; Bosnjak, Z.L.; Kwok, W.M. Cannabinoid CB1 receptor-mediated inhibition of prolactin release and signaling mechanisms in GH4C1 cells. Endocrinology 2000, 141, 1675-1685.
163. Meldeson, J.H.; Mello, N.K.; Ellingboe, J.; Skupny, A.S.; Lex, B.W.; Griffin, M. Marijuana smoking suppresses luteinizing hormone in women. J. Pharmacol. Exp. Ther. 1986, 237, 862-866.
164. Symons, A.M.; Teale, J.D.; Marks, V. Proceedings: effect of Δ9-tetrahydrocannabinol on the hypothalamic-pituitary-gonadal system in the maturing male rat. J. Endocrinol. 1976; 68, 43-44.
165. Dixit, V.P.; Sharma, V.N.; Lohiya, N.K. The effect of chronically administered cannabis extract on the testicular function of mice. Eur. J. Pharmacol. 1974, 26, 111-114.
166. Fernandez-Solari, J.; Scorticati, C.; Mohn, C.; De Laurentis, A.; Billi, S.; Franchi, A.; McCann, S.M.; Rettori, V. Alcohol inhibits luteinizing hormone-releasing hormone release by activating the endocannabinoid system. Proc. Natl. Acad. Sci. USA 2004, 101, 3264-3268.
167. Scorticati, C.; Fernandez-Solari, J.; De Laurentis, A.; Mohn, C.; Prestifilippo, J.P.; Lasaga, M.; Seilicovich, A.; Billi, S.; Franchi, A.; McCann, S.M.; et al. The inhibitory effect of anandamide on luteinizing hormone-releasing hormone secretion is reversed by estrogen. Proc. Natl. Acad. Sci. USA 2004, 101, 11891-11896.
168. de Miguel, R.; Romero, J.; Munoz, R.M.; Garcia-Gil, L.; Gonzalez, S.; Villanua, M.A.; Makriyannis, A.; Ramos, J.A.; Fernandez-Ruiz, J.J. Effects of cannabinoids on prolactin and gonadotropin secretion: involvement of changes in hypothalamic gamma-aminobutyric acid (GABA) inputs. Biochem. Pharmacol. 1998, 56, 1331-1338.
169. Gammon, C.M.; Freeman, G.M.; Xie, W.; Petersen, S.L.; Wetsel, W. Regulation of gonadotropin-releasing hormone secretion by cannabinoids. Endocrinology 2005, 146, 4491-4499.
170. Todman, M.G.; Han, S.K.; Herbison, A.E. Profiling neurotransmitter receptor expression in mouse gonadotropin-releasing hormone neurons using green fluorescent protein-promoter transgenics and microarrays. Neuroscience 2005, 132, 705-712.
171. Herrick, C.J. The brain of the tiger salamander. Chicago 1948: The University of Chicago Press.
172. Fasano, S.; Goos, G.J.; Janssen, C.; Pierantoni, R. Two GnRHs fluctuate in correlation with androgen levels in the male frog Rana esculenta. J. Exp. Zool. 1993, 266, 277-283.
173. Chianese, R.; Cobellis, G.; Pierantoni, R.; Fasano, S.; Meccariello, R. Non-mammalian vertebrate models and the endocannabinoid system: relationship with gonadotropin-releasing hormone. Mol. Cell Endocrinol. 2008, 286, S46-51.
174. Fernandez-Fernandez, R.; Martini, A.C.; Navarro, V.M.; Castellano, J.M.; Dieguez, C.; Aguilar, E.; Pinilla, L.; Tena-Sempere, M. Novel signals for the integration of energy bilance and reproduction. Mol. Cell Endocrinol. 2006, 254-255, 127-132.
175. Wynne, K.; Stanley, S.; McGowan, B.; Bloom, S. Appetite control. J. Endocrinol. 2005, 184, 291-318.
176. Hatami-Baroogh, L.; Razavi, S.; Zarkesh-Esfahani, H.; Tavalaee, M.; Tanhaei, S.; Ghaedi, K.; Deemeh, M.R.; Rabiee, F.; Nasr-Esfahani, M.H. Evaluation of the leptin receptor in human spermatozoa. Reprod. Biol. Endocrinol. 2010, 23, 8-17.
177. Arias-Alvarez, M.; Garcia-Garcia, R.M.; Torres-Rovira, L.; Gonzalez-Bulnes, A.; Rebollar, P.G.; Lorenzo, P.L. Influence of leptin on in vitro maturation and steroidogenic secretion of cumulusoocyte complexes through JAK2/STAT3 and MEK1/2 pathways in the rabbit model. Reproduction 2010, 139, 523-532.
178. Sarkar, M.; Schilffarth, S.; Scams, D.; Meyer, H.H.; Berisha, B. The expression of leptin and its receptor during different physiological stages in the bovine ovary. Mol. Reprod. Dev. 2010, 77, 174-181.
179. Mah, P.M.; Wittert, G.A. Obesity and testicular function. Mol. Cell. Endocrinol. 2010, 316, 180-186.
180. Backholer, K.; Smith, J.T.; Rao, A.; Pereira, A.; Iqbal, J.; Ogawa, S.; Li, Q.; Clarke, I.J. Kisspeptin cells in the ewe brain respond to leptin and communicate with neuropeptides Y and proopiomelanocortin cells. Endocrinology 2010, 151, in press.
181. Popa, S.M.; Clifton, D.K.; Steiner, R.A. The role of kisspeptins and GPR54 in the neuroendocrine regulation of reproduction. Annu. Rev. Physiol. 2008, 70, 213-238.
182. Tena-Sempere, M. Kiss-1 and reproduction: focus on its role in the metabolic regulation of fertility. Neuroendocrinology 2006, 83, 275-281.
183. Di Marzo, V.; Goparaju, S.K.; Wang, L.; Liu, J.; Batkai, S.; Jarai, Z.; Fezza, F.; Miura, G.I.; Palmiter, R.D.; Sugiura, T.; et al. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 2001, 410, 822-825.
184. Hanus, L.; Avraham, Y.; Ben-Shushan, D.; Zolotarev, O.; Berry, E.M.; Mechoulam, R. Shortterm fasting and prolonged semistarvation have opposite effects on 2-AG levels in mouse brain. Brain Res. 2003, 983, 144-151.
185. Mani, S.K.; Mitchell, A.; O'Malley, B.W. Progesterone receptor and dopamine receptors are required in Δ9-tetrahydrocannabinol modulation of sexual receptivity in female rats. Proc. Natl. Acad. Sci. USA 2001, 98, 1249-1254.
186. Mani, S.K.; Allen, J.M.C.; Lydon, J.P.; Mulac-Jericevic, B.; Blaustein, J.D.; DeMayo, F.J.; Conneely, O.M.; O'Malley, B.W. Dopamine requires unoccupied progesterone receptor to induce sex behavior in mice. Mol. Endocrinol. 1996, 10, 1728-1737.
187. Turley, W.A.; Floody, O.R. Delta-9-tetrahydrocannabinol stimulates receptive and proceptive sexual behaviors in female hamsters. Pharmacol. Biochem. Behav. 1981, 14, 745-747.
188. Coddington, E.; Moore, F.L. Neuroendocrinology of context-dependent stress responses: vasocitin alters the effect of corticosterone on amphibian behaviors. Horm. Behav. 2003, 43, 222-228.
189. Coddington, E.; Lewis, C.; Rose, J.D.; Moore, F.L. Endocannabinoids mediate the effects of acute stress and corticosterone on sex behavior. Endocrinology 2007, 148, 493-500.
190. Wetzel, D.M., Kelley, D.B. Androgen and gonadotropin effects on male mate calls in South African clawed frogs, Xenopus laevis. Horm. Behav. 1983, 17, 388-404.
191. Kelley, D.B.; Denninson, J. The vocal motor neurons of Xenopus laevis: development of sex differences in axon number. J. Neurobiol. 1990, 21, 869-882.
192. Brahic, C.J.; Kelley, D.B. Vocal circuitry in Xenopus laevis telencephalon to laryngeal motor neurons. J. Comp. Neurol. 2003, 464, 115-130.
193. Cottone, E.; Guastalla, A.; Mackie, K.; Franzoni, M.F. Endocannabinoids affect the reproductive functions in teleosts and amphibian. Mol. Cell Endocrinol. 2008, 286, S41-S45.
194. Burmeister, S.; Somes, C.; Wilczynski, W. Behavioral and hormonal effects of exogenous vasotocin and corticosterone in the green treefrog. Gen. Comp. Endocrinol. 2001, 122, 189-197.
195. Zornik, E.; Kelley, D.B. Breathing and calling: neuronal networks in the Xenopus laevis hindbrain. J. Comp. Neurol. 2007, 501, 303-315.
196. Pierantoni, R.; Cobellis, G.; Meccariello, R.; Cacciola, G.; Chianese, R.; Chioccarelli, T.; Fasano, S. CB1 activity in male reproduction: mammalian and nonmammalian animal models. Vitam. Horm. 2009, 81, 367-387.
197. Kalantaridou, S.N.; Makrigiannakis, A.; Zoumakis,E.; Chrousos, G.P. Reproductive functions of corticotropin-releasing hormone. Research and potential clinical utility of antalarmins (CRH receptor type 1 antagonists). Am. J. Reprod. Immunol. 2004, 51, 269-274.
198. Dubey, A.K.; Plant, T.M. A suppression of gonadotropin secretion by cortisol in castrated male reshus monkeys (Macaca mulatta) mediated by the interruption of hypothalamic gonadotropinrelesasing hormone release Biol. Reprod. 1985, 33, 423-431.
199. Lerman, S.A.; Miller, G.K.; Bohlman, K.; Albaladejo, V.; Leonard, J.F.; Devas, V.; Clark, R.L. Effects of corticosterone on reproduction in male Sprague-Dawley rats. Reprod. Toxicol. 1997, 11, 799-805.
200. Rivier, C.; Rivest, S. Effect of stress on the activity of the hypothalamic-pituitary-gonadal axis: peripheral and central mechanisms. Biol. Reprod. 1991, 45, 523-532.
201. Tsutsui, K.; Saigoh, E.; Ukana, K.; Teranishi, H.; Fujisawa, Y.; Kikuchi, M.; Ishii, S.; Sharp, P.J. A novel avian hypothalamic peptide inhibiting gonadotropin release. Biochem. Biophys. Res. Commun. 2000, 275, 661-667.
202. Kirby, E.D.; Geraghty, A.C.; Ubuka, T.; Bently, G.E.; Kaufer, D. Stress increases putative gonadotropin inhibitory hormone and decreases luteinizing hormone in male rats. Proc. Natl. Acad. Sci. USA 2009, 106, 11324-11329.
203. Patel, S.; Hillard, C.J. Adaptations in endocannabinoid signalling in response to repeated homotypic stress: a novel mechanism for stress habituation. Eur. J. Neurosci. 2008, 27, 2821-2829.
204. Ledent, C.; Valverde, O.; Cossu, G.; Petitet, F.; Aubert, J.F.; Beslot, F.; Bohme, G.A.; Imperato, A.; Pedrazzini, T.; Roques, B.P.; Vassart, G.; Fratta, W.; Parmentier, M. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 1999, 283, 401-404.
205. Wenger, T.; Ledent, C.; Tramu, G. The endogenous cannabinoid, anandamide, activates the hypothalamo-pituitary-adrenal axis in CB1 cannabinoid receptor knockout mice. Neuroendocrinology 2003, 78, 294-300.
206. Van Pett, K.; Viau, V.; Bittencourt, J.C.; Chan, R.K.; Li, H.Y.; Arias, C.; Prins, G.S.; Perrin, M.; Vale, W.; Sawchenko, P.E. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J. Comp. Neurol. 2000, 428, 191-212.
207. Hermann, H.; Lutz, B. Coexpression of the cannabinoid receptor type 1 with the corticotrophinreleasing hormone receptor type 1 in distinct regions of the adult mouse forebrain. Neurosci. Lett. 2005, 375, 13-18.
208. Cyr, N.E.; Romero, L.M. Identifying hormonal habituation in field studies of stress. Gen. Comp. Endocrinology 2009, 161, 295-303.
209. Hill, M.N.; McLaughlin, R.J.; Bingham, B.; Shrestha, L.; Lee, T.T.Y.; Megan Gray, J.; Hillard, C.J.; Gorzalka, B.B.; Viau, V. Endogenous cannabinoid signalling is essential for stress adaptation. Proc. Natl. Acad. Sci. USA 2010, 107, 9406-9411.
210. Patel, S.; Roelke, C.T.; Rademacher, D.J.; Cullinan, W.E.; Hillard, C.J. Endocannabinoid signalling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis. Endocrinology 2004, 145, 5431-5438.
211. Bayatti, N.; Hermann, H.; Lutz, B.; Behl, C. Corticotropin-releasing hormone-mediated induction of intracellular signaling pathways and brain-derived neurotrophic factor expression is inhibited by the activation of the endocannabinoid system. Endocrinology 2005, 146, 1205-1213.
212. Di Marzo, V. The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutical exploitation. Pharmacol. Res. 2009, 60, 77-84.
213. Fawcett, D.W.; Leak, L.V.; Heidger, P.M., Jr. Electron microscopic observations on the structural components of the blood-testis barrier. J. Reprod. Fertil. Suppl 1970, 10, 105-122.
214. Heindel, J.J., Keith, W.B. Specific inhibition of FSH-stimulated cAMP accumulation by delta 9- tetrahydrocannabinol in cultures of rat Sertoli cells. Toxicol. Appl. Pharmacol. 1989, 101, 124-134.
215. Leblond, C.P.; Clermont,Y. Spermiogenesis of rat, mouse, hamster and guinea pig as revealed by the periodic acid-fuchsin sulfurous acid technique. Am. J. Anat. 1952, 90, 167-215.
216. Ross, M.H. The Sertoli cell junctional specialization during spermiogenesis and at spermiation. Anat. Rec. 1976, 186, 79-87.
217. Harclerode, J. Endocrine effects of marijuana in the male: preclinical studies. NIDA Res. Monogr. 1984, 44, 46-64.
218. Dalterio, S.; Badr, F.; Bartke, A.; Mayfield, D. Cannabinoids in male mice: effects on fertility and spermatogenesis. Science 1982, 216, 315-316.
219. Dalterio, S.; Bartke, A.; Roberson, C.; Watson, D.; Burstein, S. Direct and pituitary-mediated effects of delta9-THC and cannabinol on the testis. Pharmacol. Biochem. Behav. 1978, 8, 673-678.
220. Fujimoto, G.I.; Morrill, G.A.; O'Connell, M.E.; Kostellow, A.B.; Retura, G. Effects of cannabinoids given orally and reduced appetite on the male rat reproductive system. Pharmacol. 1982, 24, 303-313.
221. Wang, H.; Dey, S.K.; Maccarrone, M. Jekyll and Hyde: two faces of cannabinoid signaling in male and female fertility. Endocr. Rev. 2006, 27, 427-448.
222. Pierantoni, R.; Cobellis, G.; Meccariello, R.; Cacciola, G.; Chianese, R.; Chioccarelli, T.; Fasano, S. Testicular gonadotropin-releasing hormone activity, progression of spermatogenesis, and sperm transport in vertebrates. Ann. N. Y. Acad. Sci. 2009, 1163, 279-291.
223. Sun, X.; Wang, H.; Okabe, M.; Mackie, K.; Kingsley, P.J.; Marnett, L.J.; Cravatt, B.F.; Dey, S.K. Genetic loss of Faah compromises male fertility in mice. Biol. Reprod. 2009, 80, 235-242.
224. Cobellis, G.; Cacciola, G.; Scarpa, D.; Meccariello, R.; Chianese, R.; Franzoni, M.F.; Mackie, K.; Pierantoni, R.; Fasano, S. Endocannabinoid system in frog and rodent testis: type-1 cannabinoid receptor and fatty acid amide hydrolase activity in male germ cells. Biol. Reprod. 2006, 75, 82-89.
225. Cacciola, G.; Chioccarelli, T.; Mackie, K.; Meccariello, R.; Ledent, C.; Fasano, S.; Pierantoni, R.; Cobellis, G. Expression of type-1 cannabinoid receptor during rat postnatal testicular development: possible involvement in adult leydig cell differentiation. Biol. Reprod. 2008, 79, 758-765.
226. Maccarrone, M.; Cecconi, S.; Rossi, G.; Battista, N.; Pauselli, R.; Finazzi-Agro, A. Anandamide activity and degradation are regulated by early postnatal aging and follicle-stimulating hormone in mouse Sertoli cells. Endocrinology 2003, 144, 20-28.
227. Rossi, G.; Gasperi, V.; Paro, R.; Barsacchi, D.; Cecconi, S.; Maccarrone, M. Follicle-stimulating hormone activates fatty acid amide hydrolase by protein kinase A and aromatase-dependent pathways in mouse primary Sertoli cells. Endocrinology 2007, 148, 1431-1439.
228. Sharpe, R.M.; McKinnell, C.; Kivlin, C.; Fisher, J.S. Proliferation and functional maturation of Sertoli cells, and their relevance to disorders of testis function in adulthood. Reproduction 2003, 125, 769-784.
229. Atanassova, N.; McKinnell, C.; Walker, M.; Turner, K.J.; Fisher, J.S.; Morley, M.; Millar, M.R.; Groome, N.P.; Sharpe, R.M. Permanent effects of neonatal estrogen exposure in rats on reproductive hormone levels, Sertoli cell number, and the efficiency of spermatogenesis in adulthood. Endocrinology 1999, 140, 5364-5373.
230. Rastogi, R.K. The control of spermatogenesis in the green frog, Rana esculenta. J. Exp. Zool. 1976, 169, 151-166.
231. D'Istria, M.; Delrio, G.; Botte, V.; Chieffi, G. Radioimmunoassay of testosterone, 17betaoestradiol and oestrone in the male and female plasma of plasma of Rana esculenta during sexual cycle. Steroids Lipids Res. 1974, 5, 42-48.
232. Pierantoni, R.; Iela, L.; d'Istria, M.; Fasano, S.; Rastogi, R.K.; Delrio, G. Seasonal testosterone profile and testicular responsiveness to pituitary factors and gonadotrophin releasing hormone during two different phases of the sexual cycle of the frog (Rana esculenta). J. Endocrinol. 1984, 102, 387-392.
233. Meccariello, R.; Chianese, R.; Cobellis, G.; Pierantoni, R.; Fasano, S. Cloning of type 1 cannabinoid receptor in Rana esculenta reveals differences between genomic sequence and cDNA. FEBS J. 2007, 274, 2909-2920.
234. Tsai, S.J.; Wang, Y.C.; Hong, C.J. Association study of a cannabinoid receptor gene (CNR1) polymorphism and schizophrenia. Psychiatr Genet. 2000, 10, 149-151.
235. Martínez-Gras, I.; Hoenicka, J.; Ponce, G.; Rodríguez-Jiménez, R.; Jiménez-Arriero, M.A.; Pérez-Hernandez, E.; Ampuero, I.; Ramos-Atance, J.A.; Palomo, T.; Rubio, G. (AAT)n repeat in the cannabinoid receptor gene, CNR1: association with schizophrenia in a Spanish population. Eur Arch Psychiatry Clin Neurosci. 2006, 256, 437-441.
236. Fasano, S.; Meccariello, R.; Cobellis, G.; Chianese, R.; Cacciola, G.; Chioccarelli, T.; Pierantoni, R. The endocannabinoid system: an ancient signaling involved in the control of male fertility. Ann. N. Y. Acad. Sci. 2009, 1163, 112-124.
237. Gye, M.C.; Kang, H.H.; Kang, H.J. Expression of cannabinoid receptor 1 in mouse testes. Arch. Androl 2005, 51, 247-255.
238. Cacciola, G.; Chioccarelli, T.; Ricci, G.; Meccariello, R.; Fasano, S.; Pierantoni, R.; Cobellis, G. The endocannabinoid system in vertebrate male reproduction: a comparative overview. Mol. Cell. Endocrinology 2008, 286, S24-S30.
239. Habert, R.; Lejeune, H.; Saez, J.M. Origin, differentiation and regulation of fetal and adult Leydig cells. Mol. Cell. Endocrinol. 2001, 179, 47-74.
240. Liu, Q.R.; Pan, C.H.; Hishimoto, A.; Li, C.Y.; Xi, Z.X.; Llorente-Berzal, A.; Viveros, M.P.; Ishiguro, H.; Arinami, T.; Onaivi, E.S.; Uhl, G.R. Species differences in cannabinoid receptor 2 (CNR2 gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands. Genes Brain Behav. 2009, 8, 519-530.
241. Mizrak, S.C.; van Dissel-Emiliani, F.M. Transient receptor potential vanilloid receptor-1 confers heat resistance to male germ cells. Fertil. Steril. 2008, 90, 1290-1293.
242. Yanagimachi, R. Fertility of mammalian spermatozoa: its development and relativity. Zygote 1994, 2, 371-372.
243. Orgebin-Crist MC. Sperm maturation in rabbit epididymis. Nature 1967, 216, 816-818.
244. Suarez, S.S.; Pacey, A.A. Sperm transport in the female reproductive tract. Hum. Reprod. Update 2006, 12, 23-37.
245. Ho, H.C.; Suarez, S.S. Hyperactivation of mammalian spermatozoa: function and regulation. Reproduction 2001, 122, 519-526.
246. Wassarman, P.; Chen, J.; Cohen, N.; Litscher, E.; Liu, C.; Qi, H.; Williams, Z. Structure and function of the mammalian egg zona pellucida. J. Exp. Zool. 1999, 285, 251-258.
247. Cobellis, G.; Ricci, G.; Cacciola, G.; Orlando, P.; Petrosino, S.; Cascio, M.G.; Bisogno, T.; De Petrocellis, L.; Chioccarelli, T.; Altucci, L.; Fasano, S.; Meccariello, R.; Pierantoni, R.; Ledent, C.; Di Marzo, V. A gradient of 2-arachidonoylglycerol regulates mouse epididymal sperm cell start-up. Biol. Reprod. 2010, 82, 451-458.
248. Schuel, H.; Burkman, L.J.; Lippes, J.; Crickard, K.; Forester, E.; Piomelli, D.; Giuffrida, A. NAcylethanolamines in human reproductive fluids. Chem. Phys. Lipids 2002, 121, 211-227.
249. Nahas, G.G.; Frick, H.C.; Lattimer, J.K.; Latour, C.; Harvey, D. Pharmacokinetics of THC in brain and testis, male gametotoxicity and premature apoptosis of spermatozoa.Hum. Psychopharmacol. 2002, 17, 103-113.
250. Francavilla, F.; Battista, N.; Barbonetti, A.; Vassallo, M.R.; Rapino, C.; Antonangelo, C.; Pasquariello, N.; Catanzaro, G.; Barboni, B.; Maccarrone, M. Characterization of the endocannabinoid system in human spermatozoa and involvement of transient receptor potential vanilloid 1 receptor in their fertilizing ability. Endocrinology 2009, 150, 4692-4700.
251. Schuel, H.; Burkman, L.J.; Lippes, J.; Crickard, K.; Mahony, M.C.; Giuffrida, A.; Picone, R.P.; Makriyannis, A. Evidence that anandamide-signaling regulates human sperm functions required for fertilization. Mol. Reprod. Dev. 2002, 63, 376-387.
252. Aquila, S.; Guido, C.; Santoro, A.; Perrotta, I.; Laezza, C.; Bifulco, M.; Sebastiano, A. Human sperm anatomy: ultrastructural localization of the cannabinoid1 receptor and a potential role of anandamide in sperm survival and acrosome reaction. Anat. Rec. (Hoboken) 2010, 293, 298-309.
253. Rossato, M.; Ion, P.F.; Ferigo, M.; Clari, G.; Foresta, C. Human sperm express cannabinoid receptor Cb1, the activation of which inhibits motility, acrosome reaction, and mitochondrial function. J. Clin. Endocrinol. Metab. 2005, 90, 984-991.
254. Agirregoitia, E.; Carracedo, A.; Subiran, N.; Valdivia, A.; Agirregoitia, N.; Peralta, L.; Velasco, G.; Irazusta, J. The CB(2) cannabinoid receptor regulates human sperm cell motility. Fertil. Steril. 2010, 93, 1378-1387.
255. Chang, M.C.; Berkery, D.; Schuel, R.; Laychock, S.G.; Zimmerman, A.M.; Zimmerman, S.; Schuel, H. Evidence for a cannabinoid receptor in sea urchin sperm and its role in blockade of the acrosome reaction. Mol. Reprod. Dev. 1993, 36, 507-516.
256. Schuel, H.; Burkman, L.J. A tale of two cells: endocannabinoid-signaling regulates functions of neurons and sperm. Biol. Reprod. 2005, 73, 1078-1086.
257. Ricci, G.; Cacciola,G.; Altucci,L.; Meccariello,R.; Pierantoni,R.; Fasano,S.; Cobellis,G. Endocannabinoid control of sperm motility: the role of epididymus. Gen. Comp. Endocrinol. 2007, 153, 320-322.
258. Aquila, S.; Guido, C.; Laezza, C.; Santoro, A.; Pezzi, V.; Panza, S.; Andò, S.; Bifulco, M. A new role of anandamide in human sperm: focus on metabolism. J. Cell. Physiol. 2009, 221, 147-153.
259. Welch, J.E.; Brown, P.L.; O'Brien, D.A.; Magyar, P.L.; Bunch, D.O.; Mori, C.; Eddy, E.M. Human glyceraldehyde 3-phosphate dehydrogenase-2 gene is expressed specifically in spermatogenic cells. J. Androl. 2000, 21, 328-338.
260. Miki, K.; Qu, W.; Goulding, E.H.; Willis, W.D.; Bunch, D.O.; Strader, L.F.; Perreault, S.D.; Eddy, E.M.; O'Brien, D.A. Glyceraldehyde 3-phosphate dehydrogenase-S, a sperm-specific glycolytic enzyme, is required for sperm motility and male fertility. Proc. Natl. Acad. Sci. USA 2004, 101, 16501-16506.
261. Windsor, D.P.; White, I.G. Assessment of ram sperm mitochondrial function by quantitative determination of sperm rhodamine 123 accumulation. Mol. Reprod. Dev. 1993, 36, 354-360.
262. Ballester, J.; Fernández-Novell, J.M.; Rutllant, J.; García-Rocha, M.; Jesús Palomo, M.; Mogas, T.; Peña, A.; Rigau, T.; Guinovart, J.J.; Rodríguez-Gil, J.E. Evidence for a functional glycogen metabolism in mature mammalian spermatozoa. Mol. Reprod. Dev. 2000, 56, 207-219.
263. Reeve, V.C.; Grant, J.D.; Robertson, W.; Gillespie, H.K.; Hollister, L.E. Plasma concentrations of delta-9-tetrahydrocannabinol and impaired motor function. Drug Alcohol Depend. 1983, 11, 167-175.
264. Whan, L.B.; West, M.C.; McClure, N.; Lewis, S.E. Effects of delta-9-tetrahydrocannabinol, the primary psychoactive cannabinoid in marijuana, on human sperm function in vitro. Fertil. Steril. 2006, 85, 653-660.
265. Badawy, Z.S.; Chohan, K.R.; Whyte, D.A.; Penefsky, H.S.; Brown, O.M.; Souid, A.K. Cannabinoids inhibit the respiration of human sperm. Fertil. Steril. 2009, 91, 2471-2476.
266. Gervasi, M.G.; Rapanelli, M.; Ribeiro, M.L.; Farina, M.; Billi, S.; Franchi, A.M.; Perez, M.S. The endocannabinoid system in bull sperm and bovine oviductal epithelium: role of anandamide in sperm-oviduct interaction. Reproduction 2009, 137, 403-414.
267. Howlett, A.C.; Barth, F.; Bonner, T.I.; Cabral, G.; Casellas, P.; Devane, W.A.; Felder, C.C.; Herkenham, M.; Mackie, K.; Martin, B.R.; Mechoulam, R.; Pertwee, R.G. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 2002, 54, 161-202.
268. Darszon, A.; Labarca, P.; Nishigaki, T.; Espinosa, F. Ion channels in sperm physiology. Physiol Rev. 1999, 79, 481-510.
269. Battista, N.; Rapino, C.; Di Tommaso, M.; Bari, M.; Pasquariello, N.; Maccarrone, M. Regulation of male fertility by the endocannabinoid system. Mol. Cell. Endocrinol. 2008, 286, S17-S23.
270. Maykut, M.O. Health consequences of acute and chronic marihuana use. Prog. Neuropsychopharmacol. Biol. Psychiatry. 1985, 9, 209-238.
271. Pope, H.G., Jr.; Yurgelun-Todd, D. The residual cognitive effects of heavy marijuana use in college students. JAMA 1996, 275, 521-527.
272. Bäckström, C.T.; McNeilly, A.S.; Leask, R.M.; Baird, D.T. Pulsatile secretion of LH, FSH, prolactin, oestradiol and progesterone during the human menstrual cycle. Clin. Endocrinol. 1982, 17, 29-42.
273. Bauman, J.E. Comparison of radioimmunoassay results in serum and plasma. Clin. Chem. 1980, 26, 676-677.
274. Mueller, B.A.; Daling, J.R.; Weiss, N.S; Moore, D.E. Recreational drug use and the risk of primary infertility. Epidemiology 1990, 1, 195-200.
275. Klonoff-Cohen, H.S.; Natarajan, L.; Chen, R.V. A prospective study of the effects of female and male marijuana use on in vitro fertilization (IVF) and gamete intrafallopian transfer (GIFT) outcomes. Am. J. Obstet. Gynecol. 2006, 194, 369-376.
276. Murphy, L.L.; Muñoz, R.M.; Adrian, B.A.; Villanúa, M.A. Function of cannabinoid receptors in the neuroendocrine regulation of hormone secretion. Neurobiol. Dis. 1998, 5, 432-346.
277. Tyrey, L. delta 9-Tetrahydrocannabinol: a potent inhibitor of episodic luteinizing hormone secretion. J. Pharmacol.Exp. Ther. 1980, 213, 306-308.
278. Adashi, E.Y.; Jones, P.B.; Hsueh, A.J. Direct antigonadal activity of cannabinoids: suppression of rat granulosa cell functions. Am. J. Physiol. 1983, 244, E177-185.
279. Nir, I.; Ayalon, D.; Tsafriri, A.; Cordova, T.; Lindner, H.R. Suppression of the cyclic surge of luteinizing hormone secretion and of ovulation in the rat by delta 1-tetrahydrocannabinol Nature 1973, 243, 470-471.
280. Ayalon, D.; Nir, I.; Cordova, T.; Bauminger, S.; Puder, M.; Naor, Z.; Kashi, R.; Zor, U.; Harell, A.; Lindner, H.R. Acute effect of delta1-tetrahydrocannabinol on the hypothalamo-pituitaryovarian axis in the rat. Neuroendocrinology 1977, 23, 31-42.
281. Smith, C.G.; Besch, N.F. Smith, R.G.; Besch, P.K. Effect of tetrahydrocannabinol on the hypothalamic-pituitary axis in the ovariectomized rhesus monkey. Fertil. Steril. 1979, 31, 335-339.
282. Reich, R.; Laufer, N.; Lewysohn, O.; Cordova, T.; Ayalon, D.; Tsafriri, A. In vitro effects of cannabinoids on follicular function in the rat. Biol. Reprod. 1982, 27, 223-231.
283. Lewysohn, O.; Cordova, T.; Nimrod, A.; Ayalon, D. The suppressive effect of delta-1- tetrahydrocannabinol on the steroidogenic activity of rat granulosa cells in culture. Horm. Res. 1984, 19, 43-51.
284. Geber, W.F.; Schramm, L.C. Effect of marihuana extract on fetal hamsters and rabbits. Toxicol. Appl. Pharmacol. 1969, 14, 276-282.
285. Persaud, T.V.; Ellington, A.C. Cannabis in early pregnancy. Lancet 1967, 2, 1306.
286. El-Talatini, M.R.; Taylor, A.H.; Elson, J.C.; Brown, L.; Davidson, A.C.; Konje, J.C. Localisation and function of the endocannabinoid system in the human ovary. PLoS One 2009, 4, e4579.
287. El-Talatini, M.R.; Taylor, A.H.; Konje, J.C. The relationship between plasma levels of the endocannabinoid, anandamide, sex steroids, and gonadotrophins during the menstrual cycle. Fertil. Steril. 2010, 93, 1989-1996.
288. Wassarman, P.M.; Jovine, L.; Litscher, E.S. A profile of fertilization in mammals. Nat. Cell. Biol. 2001, 3, E59-E64.
289. Psychoyos, A. Hormonal control of ovoimplantation. Vitam. Horm. 1973, 31, 201-256.
290. Paria, B.C.; Das, S.K.; Dey, S.K. The preimplantation mouse embryo is a target for cannabinoid ligand-receptor signaling. Proc. Natl. Acad. Sci. USA 1995, 92, 9460-9464.
291. Paria, B.C.; Ma, W.; Andrenyak, D.M.; Schmid, P.C.; Schmid, H.H.; Moody, D.E. Deng, H.; Makriyannis, A.; Dey, S.K. Effects of cannabinoids on preimplantation mouse embryo development and implantation are mediated by brain-type cannabinoid receptors. Biol. Reprod. 1998, 58, 1490-1495.
292. Paria, B.C.; Song, H.; Wang, X.; Schmid, P.C.; Krebsbach, R.J.; Schmid, H.H.; Bonner, T.I.; Zimmer, A.; Dey, S.K. Dysregulated cannabinoid signaling disrupts uterine receptivity for embryo implantation. J. Biol. Chem. 2001, 276, 20523-20538.
293. Wang, H.; Guo, Y.; Wang, D.; Kingsley, P.J., Marnett, L.J.; Das, S.K.; DuBois, R.N.; Dey, S.K. Aberrant cannabinoid signaling impairs oviductal transport of embryos. Nat. Med. 2004, 10, 1074-1080.
294. Buckley, N.E.; McCoy, K.L.; Mezey, E.; Bonner, T.; Zimmer, A.; Felder, C.C.; Glass, M.; Zimmer, A. Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor. Eur. J. Pharmacol. 2000, 396, 141-149.
295. Heilman, R.D.; Reo, R.R.; Hahn, D.W. Changes in the sensitivity of adrenergic receptors in the oviduct during early gestation in the rabbit. Fertil. Steril. 1976, 27, 426-430.
296. Horne, A.W.; Phillips, J.A., III; Kane, N.; Lourenco, P.C.; McDonald, S.E.; Williams, A.R.; Simon, C.; Dey, S.K.; Critchley, H.O. CB1 expression is attenuated in Fallopian tube and decidua of women with ectopic pregnancy. PLoS One 2008, 3, e3969.
297. Paria, B.C.; Huet-Hudson, Y.M.; Dey, S.K. Blastocyst's state of activity determines the "window" of implantation in the receptive mouse uterus. Proc. Natl. Acad. Sci. USA 1993, 90, 10159-10162.
298. Huet, Y.M.; Andrews, G.K.; Dey, S.K. Modulation of c-myc protein in the mouse uterus during pregnancy and by steroid hormones. Prog. Clin. Biol.Res. 1989, 294, 401-412.
299. Yoshinaga, K.; Fujino, M. Hormonal control of implantation in the rat: inhibition by luteinizing hormone-releasing hormone and its analogues. Ciba Found. Symp. 1978, 64, 85-110.
300. Dey, S.K. Focus on implantation. Reproduction 2004, 128, 655-656.
301. Dey, S.K. Reproductive biology: fatty link to fertility. Nature 2005, 435, 34-35.
302. Martínez Orgado, J.A.; Fernández López, D.; Bonet Serra, B.; Lizasoain Hernández, I.; Romero Paredes, J. The cannabinoid system and its importance in the perinatal period. An. Pediatr. 2005, 63, 433-440.
303. Paria, B.C.; Zhao, X.; Wang, J.; Das, S.K.; Dey, S.K. Fatty-acid amide hydrolase is expressed in the mouse uterus and embryo during the periimplantation period. Biol. Reprod. 1999, 60, 1151-1157.
304. Maccarrone, M.; De Felici, M.; Bari, M.; Klinger, F.; Siracusa, G.; Finazzi-Agrò, A. Downregulation of anandamide hydrolase in mouse uterus by sex hormones. Eur. J. Biochem. 2000, 267, 2991-2997.
305. Schmid, P.C.; Paria, B.C.; Krebsbach, R.J.; Schmid, H.H.; Dey, S.K. Changes in anandamide levels in mouse uterus are associated with uterine receptivity for embryo implantation. Proc. Natl. Acad. Sci. USA 1997, 94, 4188-4192.
306. Guo, Y.; Wang, H.; Okamoto, Y.; Ueda, N.; Kingsley, P.J.; Marnett, L.J.; Schmid, H.H.; Das, S.K.; Dey, S.K. N-acylphosphatidylethanolamine-hydrolyzing phospholipase D is an important determinant of uterine anandamide levels during implantation. J. Biol. Chem. 2005, 280, 23429-234932.
307. Wang, H.; Xie, H.; Sun, X.; Kingsley, P.J.; Marnett, L.J.; Cravatt, B.F.; Dey, S.K. Differential regulation of endocannabinoid synthesis and degradation in the uterus during embryo implantation. Prost. Other Lipid. Mediat. 2007, 83, 62-74.
308. Ribeiro, M.L.; Vercelli, C.A.; Sordelli, M.; Farina, M.G.; Cervini, M.; Billi, S.; Franchi, A.M. 17beta-oestradiol and progesterone regulate anandamide synthesis in the rat uterus. Reprod. Biomed. Online 2009, 18, 209-218.
309. Wang, H.; Matsumoto, H.; Guo, Y.; Paria, B.C.; Roberts, R.L.; Dey, S.K. Differential G proteincoupled cannabinoid receptor signaling by anandamide directs blastocyst activation for implantation. Proc Natl Acad Sci USA 2003, 100, 14914-14919.
310. El-Talatini, M.R.; Taylor, A.H.; Konje, J.C. Fluctuation in anandamide levels from ovulation to early pregnancy in in-vitro fertilization-embryo transfer women, and its hormonal regulation. Hum. Reprod. 2009, 24, 1989-1998.
311. Maccarrone, M.; Bisogno, T.; Valensise, H.; Lazzarin, N.; Fezza, F.; Manna, C.; Di Marzo, V.; Finazzi-Agrò, A. Low fatty acid amide hydrolase and high anandamide levels are associated with failure to achieve an ongoing pregnancy after IVF and embryo transfer. Mol. Hum. Reprod. 2002, 8, 188-195.
312. Piccinni, M.P.; Beloni, L.; Livi, C.; Maggi, E.; Scarselli, G.; Romagnani, S. Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions. Nat. Med. 1998, 4, 1020-1024.
313. Stewart, C.L.; Cullinan, E.B. Preimplantation development of the mammalian embryo and its regulation by growth factors. Dev. Genet. 1997, 21, 91-101.
314. Szekeres-Bartho, J.; Wegmann, T.G. A progesterone-dependent immunomodulatory protein alters the Th1/Th2 balance. J. Reprod. Immunol. 1996, 31, 81-95.
315. Maccarrone, M.; Valensise, H.; Bari, M.; Lazzarin, N.; Romanini, C.; Finazzi-Agrò, A. Progesterone up-regulates anandamide hydrolase in human lymphocytes: role of cytokines and implications for fertility. J. Immunol. 2001, 166, 7183-7189.
316. Maccarrone, M.; Bari, M.; Di Rienzo, M.; Finazzi-Agrò, A.; Rossi, A. Progesterone activates fatty acid amide hydrolase (FAAH) promoter in human T lymphocytes through the transcription factor Ikaros. Evidence for a synergistic effect of leptin. J. Biol. Chem. 2003, 278, 32726-32732.
317. Habayeb, O.M.; Taylor, A.H.; Evans, M.D.; Cooke, M.;, Taylor, D.J.; Bell, S.C.; Konje, J.C. Plasma levels of the endocannabinoid anandamide in women--a potential role in pregnancy maintenance and labor? J. Clin. Endocrinol. Metab. 2004, 89, 5482-5487.
318. Nallendran, V.; Lam, P.M.; Marczylo, T.H.; Bankart, M.J.; Taylor, A.H.; Taylor, D.J.; Konje, J.C. The plasma levels of the endocannabinoid, anandamide, increase with the induction of labour. Intern. J. Obst. Gynaecol. 2010, 117, 863-869.
319. Habayeb, O.M.; Taylor, A.H.; Finney, M.; Evans, M.D.; Konje, J.C. Plasma anandamide concentration and pregnancy outcome in women with threatened miscarriage. J.A.M.A. 2008, 299, 1135-1136.
320. Marczylo, T.H.; Lam, P.M.; Amoako, A.A.; Konje, J.C. Anandamide levels in human female reproductive tissues: solid-phase extraction and measurement by ultraperformance liquid chromatography tandem mass spectrometry. Anal. Biochem. 2010, 400, 155-162.
321. Helliwell, R.J.; Chamley, L.W.; Blake-Palmer, K.; Mitchell, M.D.; Wu, J.; Kearn, C.S.; Glass, M. Characterization of the endocannabinoid system in early human pregnancy. J. Clin. Endocrinol. Metab. 2004, 89, 5168-5174.
322. Trabucco, E.; Acone, G.; Marenna, A.; Pierantoni, R.; Cacciola, G.; Chioccarelli, T.; Mackie, K.; Fasano, S.; Colacurci, N.; Meccariello, R.; Cobellis, G.; Cobellis, L. Endocannabinoid system in first trimester placenta: low FAAH and high CB1 expression characterize spontaneous miscarriage. Placenta 2009, 30, 516-522.
323. Park, B.; Gibbons, H.M.; Mitchell, M.D.; Glass, M. Identification of the CB1 cannabinoid receptor and fatty acid amide hydrolase (FAAH) in the human placenta. Placenta 2003, 24, 990-995.
324. Acone, G.; Trabucco, E.; Colacurci, N.; Cobellis, L.; Mackie, K.; Meccariello, R.; Cacciola, G.; Chioccarelli, T.; Fasano, S.; Pierantoni, R.; Cobellis, G. Low type I cannabinoid receptor levels characterize placental villous in labouring delivery. Placenta 2009, 30, 203-205.
325. Marletta, M.A. Nitric oxide synthase structure and mechanism. J. Biol. Chem. 1993, 268, 12231- 12234.
326. Fernández Celadilla, L.; Carbajo Rueda, M.; Muñoz Rodríguez, M. Prolonged inhibition of nitric oxide synthesis in pregnant rats: effects on blood pressure, fetal growth and litter size. Arch. Gynecol. Obstet. 2005, 271, 243-248.
327. Amit, I.; Thaler, Y.; Paz, Itskovitz-Eldor, J. The effect of a nitric oxide donor on Doppler flow velocity waveforms in the uterine artery during the first trimester of pregnancy. Ultras. Obstet. Gynecol. 1998, 11, 94-98.
328. Chaudhuri, G.; Cuevas, J.; Buga G.M.; Ignarro, L.J. NO is more important than PGI2 in maintaining low vascular tone in feto-placental vessels, Am. J. Physiol. 1993, 265, H2036-H2043.
329. Cella, M.; Leguizamón, G.F.; Sordelli, M.S.; Cervini, M.; Guadagnoli, T.; Ribeiro, M.L.; Franchi, A.M.; Farina, M.G. Dual effect of anandamide on rat placenta nitric oxide synthesis. Placenta 2008, 29, 699-707.
330. Mitchell, M.D.; Sato, T.A.; Wang, A.; Keelan, J.A.; Ponnampalam, A.P.; Glass, M. Cannabinoids stimulate prostaglandin production by human gestational tissues through a tissueand CB1-receptor-specific mechanism. Am. J. Physiol. Endocrinol. Metab. 2008, 294, 352-356.
331. Wang, H.; Xie, H.; Dey, S.K. Loss of cannabinoid receptor CB1 induces preterm birth. PLoS One 2008, 3, e3320.